Verosudil

Drug Profile

Verosudil

Alternative Names: AR-12286

Latest Information Update: 27 Sep 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aerie Pharmaceuticals
  • Class Acetamides; Antiglaucomas; Antihypertensives; Isoquinolines; Small molecules; Thiophenes
  • Mechanism of Action Rho-associated kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Glaucoma; Ocular hypertension

Most Recent Events

  • 27 Sep 2013 Discontinued - Phase-II for Glaucoma in USA (Ophthalmic)
  • 30 Jun 2013 Discontinued - Phase-II for Glaucoma (combination therapy) in USA (Ophthalmic)
  • 30 Jun 2013 Discontinued - Phase-II for Glaucoma in India (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top